MKI67 and COVID-19: Such studies revealed that NK cell phenotype and function are significantly altered by severe COVID-19; the peripheral NK cells of severe COVID-19 patients are highly activated and proliferative (1–6), with increased expression of cytotoxic molecules, Ki-67, and several surface markers of activation (3, 5, 7–9).